(13-096) Tolerability of Pemetrexed Treatment in Patients with Renal Insufficiency

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: University of Tennessee Medical Center
Residency Program Type: PGY2 (Oncology Pharmacy)
Residency Program Location: Tennessee

Co-Author(s): Sang Park, Natalie Hurst, Alexandra McBrayer

Primary Author(s)

Kristen J. Asprer, Pharm.D. Candidate, 2024

PGY2 Oncology Pharmacy Resident
University of Tennessee Medical Center Knoxville